Clinical Trials Directory

Trials / Completed

CompletedNCT01729208

An Evaluation of the Effectiveness of Dual Focus Soft Contact Lenses in Slowing Mypoia Progression

A Multicentre Dispensing Clinical Evaluation of MiSight® Lenses

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
144 (actual)
Sponsor
CooperVision, Inc. · Industry
Sex
All
Age
8 Years – 12 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to determine whether a new type of soft contact lens with a unique optical design (dual focus) is effective at slowing the progression of myopia (near-sightedness) in children.

Detailed description

Subjects were randomized to wear test or control soft contact lens to determine whether a new type of soft contact lens with a unique optical design (dual focus) is effective at slowing the progression of myopia (near-sightedness) in children.

Conditions

Interventions

TypeNameDescription
DEVICEDual Focus Soft Contact Lens
DEVICESingle Vision Soft Contact Lens

Timeline

Start date
2012-11-01
Primary completion
2017-05-01
Completion
2019-05-01
First posted
2012-11-20
Last updated
2020-02-24
Results posted
2020-02-24

Locations

4 sites across 4 countries: Canada, Portugal, Singapore, United Kingdom

Regulatory

Source: ClinicalTrials.gov record NCT01729208. Inclusion in this directory is not an endorsement.

An Evaluation of the Effectiveness of Dual Focus Soft Contact Lenses in Slowing Mypoia Progression (NCT01729208) · Clinical Trials Directory